首页 >
法规速递
-
Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived From Cell Lines of Human or Animal Origin (Draft)-2022/11/10
2022-11-30查看详情 > -
国家药监局综合司公开征求《关于加强委托生产药品上市许可持有人监管工作的通知 （征求意见稿）》意见-2023/5/24
2023-05-24查看详情 > -
Regulatory and procedural guideline: List of centrally authorised products requiring a notification of a change for update of annexes (updated)-2023/11/21
2023-11-23查看详情 > -
Document: CHMP PROM minutes for the meeting on 02 December 2024-2025/1/20
2025-01-21查看详情 > -
Document: Minutes of the COMP meeting 3-5 December 2024-2025/2/21
2025-02-24查看详情 > -
Page: European Sales and Use of Antimicrobials for Veterinary Medicine (ESUAvet) annual surveillance reports-2025/3/31
2025-04-01查看详情 > -
Page: Artificial intelligence-2025/5/7
2025-05-08查看详情 > -
Document: Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence for regulatory purposes-2025/6/17
2025-06-18查看详情 > -
国家药监局关于中药保护品种的公告（延长保护期第23号）（2025年第70号）-2025/7/22
2025-07-23查看详情 > -
关于公开征求《治疗间质性肺疾病的抗纤维化药物临床试验技术指导原则（征求意见稿）》意见的通知-2025/9/8
2025-09-09查看详情 >
